The virtual COPD visit during COVID-19The facts about COVID-19 and COPD and guidance on how to conduct a virtual visit Bristol-Myers Squibb discontinues Coumadin brand of warfarinGeneric alternatives still marketed, but some strengths of one generic product currently in short supply Amputations, organ failure, blood clotting: the range of complications in COVID-19 cases Being taken seriously Young MDs often have their judgment questioned by colleagues and patients; here’s how some deal with that NS to cover extra dispensing fees arising from 30-day prescription limits As NS steps up, the OPA and CARP have been lobbying Ontario to do the same Considerations for pharmacy owners/managers during COVID-19 The CPhA and Neighbourhood Pharmacies have developed a list of considerations if staff become ill or pharmacies need to close Canadian interim guidelines for managing patients with moderate to severe COVID-19 Provide advice on timely, effective and safe supportive management of adults and children with suspected or confirmed COVID-19 Oncology drugs are largest category in pipeline, review board reports Gilead seeks Health Canada approval for HIV PrEP indication for Descovy Submission based on data from the DISCOVER trial, which compared Descovy to Truvada Strategies for managing the shortage of salbutamol inhalers Canadian Thoracic Society issues guidance for managing patients with asthma and COPD during salbutamol inhaler shortage Rushing coronavirus vaccines and treatments could do more harm than good While it may seem counter-intuitive, even in times of desperate measures and rapid response, science still requires time to make rigorous and robust conclusions Majority of US independent pharmacies need coronavirus small business aid Pandemic costs final straw after years of reimbursement and cash flow declines First Previous 354 355 356 357 358 Next Last
